CLAIM CARD
Additional corpus sources included animal/preclinical evidence; within the immune corpus, notable tensions exist between studies reporting positive signals and those reporting null findings. The majority of studies in the corpus — including Joo 2024, Jurdi 2025, Wang 2017b, Leontieva 2016, Leontieva 2011, and Xu 2021 — align on null or mechanistically-focused outcomes, while Kell 2026 and Mannick 2014 represent positive signals, and Hands 2025 occupies an intermediate position with suggestive but inconclusive evidence.
Evidence grade: exploratory
Contradiction status: none
Publication: f02d4a53-03e5-47ed-9876-75a416e3bd24
Provenance: Derivation Web chain
Citation Support
source_1Moel 2025source_2Gkioni 2025source_3Smiaek 2023source_4Willows 2023source_5Harinath 2025